Product Center
Hot Products
Cholera’s Hidden Shield: How Bacteria Outsmart Viruses to Fuel Epidemics
May 23, 2025
1.The Invisible War: Cholera vs. Phages When we think of cholera, contaminated water and deadly outbreaks come to mind. However, behind the scenes, Vibrio cholerae faces a microscopic battle against viruses called bacteriophages (phages). These phages don’t just infect bacteria—they
Breakthrough Drug Targets Deadly Mycobacterial Infections in Vulnerable Patients
May 8, 2025
1.A New Weapon Against a Deadly Cousin of TB Scientists at Hackensack Meridian’s Center for Discovery and Innovation (CDI) have engineered a promising drug candidate to combat Mycobacterium abscessus—a rising threat to immunocompromised individuals and those with lung diseases like
Malawi’s UTI Crisis: Soaring Antibiotic Resistance Demands Urgent Action
May 3, 2025
1.Alarming Resistance Cripples UTI Treatment A growing resistance to antibiotics is crippling urinary tract infection (UTI) treatment in Malawi. New research reveals nearly half of women with symptoms at Zomba Central Hospital had multi-drug resistant infections, signaling a public health
New RNA-Based Test Offers Hope in Global Tuberculosis Fight
April 30, 2025
Simpler, Faster Diagnostics Could Save Lives and Reduce Overtreatment 1.Tuberculosis: A Deadly but Treatable Disease In 2023, tuberculosis (TB) killed 1.25 million people worldwide. Despite being curable, TB remains the deadliest infectious disease. Powerful antibiotics can cure 88% of cases
Vaccine Breakthrough Offers Hope for Endangered California Condors
April 18, 2025
Bird Flu Vaccine Trial Shows Strong Immune Response, Averting a Conservation Crisis 1.A Race to Save North America’s Rarest Bird In 2023, a deadly strain of bird flu (HPAI) swept through California condor populations, killing 21 birds—nearly 18% of the
New Antibiotic Breakthrough Targets Drug-Resistant MRSA Infections
April 11, 2025
Lab-Developed Gel Could Revolutionize Treatment for Skin Superbugs 1.The Growing Threat of Antibiotic Resistance Superbugs are bacteria that resist common antibiotics. Every year, millions suffer from untreatable infections. MRSA, a deadly drug-resistant staph bacteria, is a major culprit. 2.A Promising
Study Finds Single Respiratory Virus May Cause Kawasaki Disease
March 28, 2025
Study Finds Single Respiratory Virus May Cause Kawasaki Disease New research from the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago suggests that a single, unidentified respiratory virus may be the cause of
CDC Study Identifies Leading Causes of Foodborne Illness in the U.S.
March 25, 2025
A new study by the CDC reveals which foodborne pathogens are making Americans sick and how many people end up in the hospital or die. This study highlights the importance of advanced diagnostics in understanding the risks associated with foodborne
Vanderbilt’s $30M AI Mission: Faster, Smarter Antibody Therapies
March 18, 2025
1.AI vs Antibodies: A 30MQuest Vanderbilt University Medical Center(VUMC) has secured up to 30 million from the U.S. government’s ARPA-H to revolutionize antibody therapy development using artificial intelligence. The project aims to create an AI-driven platform capable of designing antibodies
Scientists Discover New Strategy to Combat Norovirus
March 7, 2025
1.A Breakthrough in Fighting a Global Threat Scientists at The University of Texas at Austin, alongside researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have uncovered a promising strategy to fight norovirus.
Synthetic Microbiome Therapy: A Breakthrough Against Dangerous Gut Infections
March 4, 2025
1.A New Approach to Fighting Stubborn Infections A synthetic microbiome therapy shows promise in fighting dangerous gut infections. Tested in mice, it combats Clostridioides difficile (C. difficile), a stubborn and potentially deadly bacterium. Researchers at Penn State developed this treatment
Study Shows How Herpes Viruses Contribute to Alzheimer’s Disease in Aging Brains
February 28, 2025
Researchers from Cleveland Clinic’s Genome Center have discovered that the herpes simplex virus-1 (HSV-1) may contribute to Alzheimer’s disease in aging brains. Their study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, suggests that two FDA-approved drugs